These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6469868)

  • 1. Chemical modification of spiramycins. II. Synthesis and antimicrobial activity of 4'-deoxy derivatives of neospiramycin I and their 12-(Z)-isomers.
    Sano H; Inoue M; Omura S
    J Antibiot (Tokyo); 1984 Jul; 37(7):738-49. PubMed ID: 6469868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical modification of spiramycins. I. Synthesis of the acetal derivatives of neospiramycin I.
    Sano H; Inoue M; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1983 Oct; 36(10):1336-44. PubMed ID: 6643282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical modification of spiramycins. V. Synthesis and antibacterial activity of 3'- or 4''-de-N-methylspiramycin I and their N-substituted derivatives.
    Sano H; Tanaka H; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1985 Feb; 38(2):186-96. PubMed ID: 3997666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical modification of spiramycins. III. Synthesis and antibacterial activities of 4''-sulfonates and 4''-alkylethers of spiramycin I.
    Sano H; Sunazuka T; Tanaka H; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1984 Jul; 37(7):750-9. PubMed ID: 6469869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical modification of spiramycins. IV. Synthesis and in vitro and in vivo activities of 3'',4''-diacylates and 3,3'',4''-triacylates of spriamycin I.
    Sano H; Sunazuka T; Tanaka H; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1984 Jul; 37(7):760-72. PubMed ID: 6469870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure activity relationships of spiramycins.
    Omura S; Sano H; Sunazuka T
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():1-11. PubMed ID: 3902764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical modification of spiramycins. VI. Synthesis and antibacterial activities of 3,3''-di-O-acyl-4''-O-sulfonyl and 3,3''-di-O-acyl-4''-O-alkyl derivatives of spiramycin I.
    Sano M; Sunazuka T; Tanaka H; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1985 Oct; 38(10):1350-8. PubMed ID: 4066488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical modification of tylosin: synthesis of amino derivatives at C-20 position of tylosin and demycarosyltylosin.
    Matsubara H; Inokoshi J; Nakagawa A; Tanaka H; Omura S
    J Antibiot (Tokyo); 1983 Dec; 36(12):1713-21. PubMed ID: 6662813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships among the O-acyl derivatives of leucomycin. Correlation of minimal inhibitory concentrations with binding to Escherichia coli ribosomes.
    Omura S; Nakagawa A; Sakakibara H; Okekawa O; Brandsch R
    J Med Chem; 1977 May; 20(5):732-6. PubMed ID: 404425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro antibacterial activity of catechol-spiramycin conjugates.
    Poras H; Kunesch G; Barrière JC; Berthaud N; Andremont A
    J Antibiot (Tokyo); 1998 Aug; 51(8):786-94. PubMed ID: 9766470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4'''-N-demethylspiramycin derivatives: synthesis and evaluation of effectiveness against drug-resistant bacteria.
    Sunazuka T; Shudo H; Nagai K; Yoshida K; Yamaguchi Y; Hanaki H; Omura S
    J Antibiot (Tokyo); 2008 Mar; 61(3):175-84. PubMed ID: 18503196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the macrolide antibiotic midecamycin. III. Formation of neoisomidecamycin.
    Omoto S; Ogino H; Iwamatsu K; Inouye S
    J Antibiot (Tokyo); 1982 Nov; 35(11):1521-6. PubMed ID: 7161192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Spiramycin derivatives. 1].
    Takahira H
    Jpn J Antibiot; 1970 Aug; 23(4):424-8. PubMed ID: 5312794
    [No Abstract]   [Full Text] [Related]  

  • 14. 1H-NMR and 13C-NMR spectral assignments of spiramycins I and III.
    Ramu K; Shringarpure S; Cooperwood S; Beale JM; Williams JS
    Pharm Res; 1994 Mar; 11(3):458-65. PubMed ID: 8008717
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of leucomycins and analogues on binding [14C ]erythromycin to Escherichia coli ribosomes.
    Pestka S; Nakagawa A; Omura S
    Antimicrob Agents Chemother; 1974 Nov; 6(5):606-12. PubMed ID: 15825314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribosome-binding activities and antimicrobial activities of tylosin and its related compounds.
    Omura S; Inokoshi J; Matsubara H; Tanaka H
    J Antibiot (Tokyo); 1983 Dec; 36(12):1709-12. PubMed ID: 6662812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-O-Mycaminosyltylonolide antibacterial derivatives: design, synthesis and bioactivity.
    Sugawara A; Maruyama H; Shibusawa S; Matsui H; Hirose T; Tsutsui A; Froyman R; Ludwig C; Koebberling J; Hanaki H; Kleefeld G; Ōmura S; Sunazuka T
    J Antibiot (Tokyo); 2017 Jul; 70(8):878-887. PubMed ID: 28559578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two novel spiramycins obtained from commercial samples: isolation and elucidation of structure.
    Liu L; Roets E; Busson R; Vankeerberghen A; Janssen G; Hoogmartens J
    J Antibiot (Tokyo); 1996 Apr; 49(4):398-401. PubMed ID: 8642006
    [No Abstract]   [Full Text] [Related]  

  • 19. Syntheses of 23-C-alkylidene, and 23-N-containing derivatives of 5-O-mycaminosyltylonolide.
    Kajikawa N; Tsuchiya T; Umezawa S; Umezawa H
    J Antibiot (Tokyo); 1987 Apr; 40(4):476-82. PubMed ID: 3583916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative analyses of spiramycin and acetylspiramycin by high performance liquid chromatography].
    Sun C; Yu RG; Yang QH; Sheng SG; Zhao XF
    Yao Xue Xue Bao; 1987 May; 22(5):354-9. PubMed ID: 3687460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.